News

September 29, 2020September 29, 2020

Most nmCRPC Patients Can Safely Take Full Dose of Nubeqa, Trial Analysis Shows

News

Nearly all men with non-metastatic castration-resistant prostate cancer (nmCRPC) received the full planned dose of Nubeqa (darolutamide) tablets while participating in the ARAMIS Phase 3 trial, and few required dose ... Read more

September 24, 2020September 24, 2020

Phase 1 Trial of Oral Treatment for Metastatic CRPC Doses First Patient

News

A first patient has been dosed in a Phase 1 clinical trial investigating the small molecule inhibitor EPI-7386 as a treatment for metastatic castration-resistant prostate cancer (CRPC), its developer, ESSA Pharma, ... Read more

September 22, 2020September 22, 2020

Lynparza’s Approval Favored in EU for mCRPC Patients with BRCA Mutations

News

Lynparza (olaparib) has been recommended for approval in the European Union to treat men with metastatic castration-resistant prostate cancer (mCRPC) who carry mutations in BRCA1 and BRCA2, two DNA repair genes. The marketing authorization application ... Read more

September 17, 2020September 17, 2020

NCI Grant to Probe Link Between Prostate Cancer and Fatty Cells in Bone Marrow

News

A five-year grant of more than $2 million from the National Cancer Institute (NCI) will support research investigating the link between prostate cancer cells and the fatty cells — adipocytes — found ... Read more

September 10, 2020September 10, 2020

NIH Grants Dartmouth Team $2.5M to Develop Device for Detecting Cancer Cells

News

A research team at the Thayer School of Engineering at Dartmouth received a $2.5 million grant to develop and test a device meant to help surgeons detect and remove prostate cancer ... Read more

September 8, 2020September 8, 2020

IPCR Launches Exercise Video Series for Prostate Cancer Patients

News

The Institute for Prostate Cancer Research (IPCR), a collaborative effort between the Fred Hutchinson Cancer Research Center and UW Medicine, has launched a video series of exercises especially designed to ... Read more

September 3, 2020September 3, 2020

‘Eat It to Beat It’ Challenge to Honor Prostate Cancer Awareness Month

News

To honor Prostate Cancer Awareness Month this September, the Prostate Cancer Foundation (PCF) has launched its “Eat It to Beat It” challenge with the endorsement of celebrity ambassador Harry Lennix, ... Read more

August 31, 2020August 31, 2020

FDA Approves Blood Test That Can Identify Cancers Eligible for Targeted Therapies

News

The U.S. Food and Drug Administration (FDA) has approved FoundationOne Liquid CDx, a blood test that can be used to identify cancer patients who may benefit from certain targeted therapies, including ... Read more

August 25, 2020August 25, 2020

Tolmar Affirms Full Supply of Eligard for Palliative Treatment of Prostate Cancer

News

Tolmar Pharmaceuticals maintains a complete inventory of Eligard (leuprolide acetate), its therapy for advanced prostate cancer, and had increased production in response to reports of shortages of other leuprolide acetate ... Read more

August 18, 2020August 18, 2020

Google AI System Outperforms General Pathologists in Grading Prostate Cancers, Study Finds

News

A novel artificial intelligence (AI) technology developed by Google is better at grading prostate cancer biopsies than general pathologists and is as good at identifying cancerous samples, a new study reports. ... Read more